Monitoring of minimal residual disease by combined detection of PML/RARα and RARα/PML rearrangements in acute promyelocytic leukemia;Monitorización de la enfermedad mínima residual mediante detección conjunta de los reordenamientos PML/RARα y RARα/PML en la leucemia promielocítica aguda

Medicina Clinica

Volumn 114, Issue 8, 2000, Pages 281-285

  Bolufer Gilabert, Pascual ^a   Barragán, Eva ^a   Sanz, Miguel Ángel ^a   Martín, Guillermo ^a   Lerma, Enrique ^a   De Ribera, Esperanza Afán ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Acute promyelocytic leukemia; Minimal residual disease; Monitoring; PML RAR ; RAR PML

Indexed keywords

ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA-RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; TUMOR PROTEIN;

ARTICLE; GENE REARRANGEMENT; GENETICS; HUMAN; MINIMAL RESIDUAL DISEASE; PROMYELOCYTIC LEUKEMIA; SENSITIVITY AND SPECIFICITY;

GENE REARRANGEMENT; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; NEOPLASM PROTEINS; NEOPLASM, RESIDUAL; ONCOGENE PROTEINS, FUSION; SENSITIVITY AND SPECIFICITY;

EID: 0039923333     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(00)71270-x     Document Type: Article

References (15)

1. Pedersen-Bjergaard J, Rowley JD. The balanced and unbalanced chromosome of acute leukemia may develop different ways and may contribute differently to malignant transformation. Blood 1994; 83: 2780-2786.
2. Appelbaum FR, Downing J, William C. The biology and therapy of acute myelogenous leukemias ASH. Educational Programme. Seattle 1995; 23-25.
3. Grimwade D, Langabeer S, Howe K, Solomon E. RT-PCR in diagnosis and disease monitoring of acute promyelocytic leukemia (APL). En: Redfern CPF, editor. Methods in molecular biology. Totowa NJ: Human Press Inc., 1997; 89: 333-358.
4. Campana D, Pui Ch. Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance [revisión]. Blood 1995; 85: 1416-1434.
5. Cross NCP, Hughes TP, Feng L, O'Shea P, Bungey J, Marks DI et al. Minimal residual disease after allogenic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations acute graft-versus-host disease and relapse. Brit J Haematol 1993; 84: 67-74.
6. Sanz MA, Martín G, Rayón C, Esteve J, González M, Díaz-Mediavilla J et al, for the PETHEMA Group. A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARα-positive acute promyelocytic leukemia. Blood 1999; 94: 3015-3021.
7. Lo Coco F, Diverjo D, Pandolfi P, Biondi A, Rossi V, Avvisati G et al. Molecular evaluation of residual disease as predictor of relapse in acute promyelocytik leukemia. Lancet 1992; 340; 1437-1438.
8. Lo Coco F, Nervi C, Avvisati G, Mandelli F. Acute promyelocytic leukemia: a curable disease. Leukemia 1998; 2: 1866-1880.
9. Seale JRC, Varma S, Swirsky DM, Pandolfi PP, Goldman JM, Cross NCP. Quantitation of PML-RARα transcripts in acute promyelocytic leukaemia: explanation for the lack of sensitivity of RT-PCR for the detection of minimal residual disease and induction of the leukaemia-specific mRNA by alpha interpheron. Brit J Haemat 1996; 95: 95-101.
10. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
11. Alcalay M, Zangrilii D, Fagioli M, Pandolfi PP, Mencarelli A, Lo Coco F et al. Expression pattern of the RARα/PML fusion gene in acute promyelocytic leukemia. Proc Natl Acad Sci USA 1992; 89: 4840-4844.
12. Lo Coco F, Diverio D, Pandolfi PP, Biondi A, Rossi V, Avvisati G et al. Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukemia. Lancet 1992; 340: 1437-1438.
13. Biondi A, Rambaldi A, Pancolfi PP, Rosi V, Giudici G, Alcalay M et al. Molecular monitoring of the myl/retinoic acid receptor-α fusion gene in acute promyelocytic leukemia by polymerase chain reaction. Blood 1992; 80: 492-497.
14. Barragán WE, Bonanad S, López JA, Martin G, Martínez J, Sanz GF et al. Detección del reordenamiento PML/RARα en la leucemia promielocítica aguda mediante un método de PCR reversa. Sangre 1996; 41: 189-194.
15. Grimwade D, Howe K, Langebeer S, Burnett AK, Goldsetone A, Solomon E. Minimal residual disease detection in acute promyelocytic leukemia by reverse transcriptase PCR: evaluation of PML-RARα and RARα-PML assessment in patients who ultimately relapse. Leukemia 1996; 10: 61-66.